Table 2. Indication of flexible bronchoscopy and meta-analysis for proportion of disease.
| Indication of flexible bronchoscopy | Median | Range | Pooled proportion with 95% CI | I2 |
|---|---|---|---|---|
| Persistent/recurrent wheeze | 27 | 0–503 | 0.18 (0.17–0.2) | 81% |
| Stridor | 5 | 0–105 | 0.02 (0.01–0.03) | 93% |
| Chronic cough | 18 | 0–700 | 0.13 (0.11–0.15) | 93% |
| Persistent/recurrent pneumonia | 10 | 0–200 | 0.07 (0.06–0.09) | 91% |
| Atelectasis/lobar pneumonia | 33 | 0–1,000 | 0.26 (0.25–0.3) | 95% |
| Pulmonary nodule | 1 | 0–70 | 0.006 (0.004–0.008) | 80% |
| Interstitial pneumonia | 4 | 0–100 | 0.024 (0.018–0.03) | 91% |
| Hemoptysis | 2 | 0–100 | 0.014 (0.011–0.018) | 77% |
| Tuberculosis | 3 | 0–193 | 0.01 (0.008–0.02) | 89% |
| Suspected lung malformation | 8 | 0–500 | 0.05 (0.04–0.07) | 96% |
| Foreign body | 9 | 0–100 | 0.02 (0.01–0.03) | 84% |
| Other indication | 6 | 0–249 | 0.04 (0.02–0.05) | 97% |
Median: the median number of participant in centers; pooled proportion performed by random effect model; I2 is for statistical heterogeneity.